Sensient Technologies logo

Sensient Technologies

SXT | NYSE
Chart Builder DCF Calculator
$114.59
-$2.11 (-1.81%)
At close: Nov 16, 2026, 4:00 PM ET
$114.00
-$0.59 (-0.51%)
After-hours: Nov 16, 2026, 7:22 PM ET
-1.81%

Rating

Updated: Nov 14, 2026
58.1
Fundamentals Strong
Market Sentiment Neutral
Moat Narrow
Sector Rank #128/394 (Top 32%)

Key Statistics

Market Data

Market Cap $4.88B
1D Range
113.49 118.05
52W Range
82.96 137.45

Valuation (TTM)

PE 28.86
PB 3.79
EV/EBITDA 17.75

Valuation (NTM)

Forward PE 27.85
Forward PEG 1.57
Price Target $140.00
Loading financial charts...

Profile

Sensient Technologies Corporation, operating alongside its various subsidiaries, specializes in the creation, production, and global distribution of colors, flavorings, and an array of other specializ...

Employees 4,070
IPO Date Mar 17, 1980
Fiscal Year January - December

Latest News

Sensient Technologies: The Selloff Doesn't Fix The Valuation

15 days ago · seekingalpha.com

Sensient Technologies: The Selloff Doesn't Fix The Valuation
What Sensient Technologies (SXT) Said on Its Q3 Earnings Call

17 days ago · marketbeat.com

What Sensient Technologies (SXT) Said on Its Q3 Earnings Call
Sensient Technologies Corporation (SXT) Q3 2026 Earnings Call Transcript

18 days ago · seekingalpha.com

Sensient Technologies Corporation (SXT) Q3 2026 Earnings Call Transcript
Sensient Technologies (SXT) Beats Q3 Earnings and Revenue Estimates

18 days ago · zacks.com

Sensient Technologies (SXT) Beats Q3 Earnings and Revenue Estimates
Sensient Technologies Corporation Reports Results for the Quarter Ended September 30, 2026

18 days ago · businesswire.com

Sensient Technologies Corporation Reports Results for the Quarter Ended September 30, 2026
Sensient Declares Dividend

18 days ago · businesswire.com

Sensient Declares Dividend
China SXT Pharmaceuticals, Inc. Announces Share Consolidation

26 days ago · prnewswire.com

China SXT Pharmaceuticals, Inc. Announces Share Consolidation
China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right

27 days ago · prnewswire.com

China SXT Pharmaceuticals Inc Announces Termination of Additional Purchase Right
Sensient Announces Conference Call

1 month ago · businesswire.com

Sensient Announces Conference Call
China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

1 month ago · prnewswire.com

China SXT Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering

Earnings

Latest Earnings
Oct 30, 2026
EPS
$1.13
Beat +3.67%
REV
$455.84M
Miss -0.70%
Next Earnings
Feb 12, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$140.00
Upside
+22.17%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.